Oligohydramnios
17
3
4
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.8%
2 terminated out of 17 trials
71.4%
-15.1% vs benchmark
12%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (17)
PPROM Registry (Preterm Premature Rupture of Membranes)
Comparison Between Treatments of Oligohydramnios
"Fetal GRowth AbnorMality DEtection Trial"
Dilapan-S®: A Multicenter US E-registry
The Effect of Oral Hypotonic Hydration in Isolated Oligohydramnios
Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
Effect of Intermittent Pneumatic Compression Device of Lower Limbs in Oligohydramnios
The Added Contribution of Transvaginal Sonographic Evaluation of Amniotic Fluid Index
The Role of Zamzam Water in Idiopathic Oligohydramnios
Warfarine in Unexplained Oligohydramnios
Hydrotherapy for the Reversal of Oligohydramnios
Low Sodium Diet in Oligohydramnios Assigned for Conservative Management
Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?
Fetal Renal Artery Doppler Indices in Borderline Isolated Oligohydramnios
Active Induction of Labor in Pregnancies Complicated With Oligohydramnios at Term
Foley Catheter Versus Vaginal Misoprostol for Cervical Ripening and Induction of Labor
Amnioinfusion Initiative